• Virtual event: CAR-T comes of age?

    13 days ago - By STAT

    Editor's note: A livestream of this event will be embedded below at 1 p.m. ET.
    It's been almost a decade since the first stunning data on a cell therapy that battled blood cancer by genetically altering a patient's own white blood cells to attack it. Many years and billions of dollars in mergers and acquisitions later, CAR-T is still used mostly as a last resort. Could new clinical trials that are about to report out in full change that? STAT gathers experts to look ahead.
    Read more ...